Ziprasidone versus risperidone in schizophrenia: An eight-week, double-blind trial with forty four-week continuation

被引：3
|
作者：
Benattia, I [1 ]
Addington, D [1 ]
Pantelis, C [1 ]
Dineen, M [1 ]
Murray, S [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80431-0
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] Insulin resistance in olanzapine and ziprasidone treated subjects: Interim results of a double-blind controlled six-week trial
    O'Sullivan, R
    Fryburg, D
    Siu, C
    Simpson, G
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 241 - 241
  • [42] Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: A 12-week open-label, multicentre clinical trial
    Lublin, Henrik
    Haug, Hans-Joachim
    Koponen, Hannu
    Sigmundsson, Thordur
    Kolb, Stefan A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04): : 710 - 718
  • [43] A randomized, double-blind, comparison of risperidone versus risperidone plus haloperidol treatment in schizophrenia
    Lin, C. H.
    Kuo, C. C.
    Chou, L. S.
    Wang, S. J.
    Chen, M. C.
    Chen, C. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S256 - S256
  • [44] Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis:: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial
    Schnitzer, TJ
    Beier, J
    Geusens, P
    Hasler, P
    Patel, SK
    Senftleber, I
    Gitton, X
    Moore, A
    Sloan, VS
    Poór, G
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (04): : 549 - 557
  • [45] A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial
    Sikich, L
    Hamer, RM
    Bashford, RA
    Sheitman, BB
    Lieberman, JA
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (01) : 133 - 145
  • [46] Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia
    Findling, Robert L.
    Landbloom, Ronald P.
    Mackle, Mary
    Pallozzi, Wendi
    Braat, Sabine
    Hundt, Carla
    Wamboldt, Marianne Z.
    Mathews, Maju
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (05) : 384 - 396
  • [47] A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial
    Linmarie Sikich
    Robert M Hamer
    Robert A Bashford
    Brian B Sheitman
    Jeffrey A Lieberman
    Neuropsychopharmacology, 2004, 29 : 133 - 145
  • [48] RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF RISPERIDONE VERSUS CLOZAPINE IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA
    KLIESER, E
    LEHMANN, E
    KINZLER, E
    WURTHMANN, C
    HEINRICH, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) : S45 - S51
  • [49] Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial
    Keck, PE
    Versiani, M
    Potkin, S
    West, SA
    Giller, E
    Ice, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 741 - 748
  • [50] Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
    Zhong, Kate X.
    Sweitzer, Dennis E.
    Hamer, Robert M.
    Lieberman, Jeffrey A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (07) : 1093 - 1103
12345